Femasys Inc. (FEMY)
USD 1.08
(-5.26%)
USD 1.08
(-5.26%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | -14.5 Million USD | -25.07% |
| 2022 | -11.6 Million USD | -39.15% |
| 2021 | -8.33 Million USD | -20.25% |
| 2020 | -6.93 Million USD | 40.42% |
| 2019 | -11.63 Million USD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q2 | -4.48 Million USD | -29.44% |
| 2024 Q1 | -3.46 Million USD | 22.18% |
| 2023 Q2 | -2.93 Million USD | 3.48% |
| 2023 FY | -14.5 Million USD | -25.07% |
| 2023 Q4 | -4.44 Million USD | -9.02% |
| 2023 Q3 | -4.08 Million USD | -39.01% |
| 2023 Q1 | -3.04 Million USD | -1.38% |
| 2022 Q2 | -2.65 Million USD | 7.73% |
| 2022 Q1 | -2.88 Million USD | -22.27% |
| 2022 Q4 | -3 Million USD | 1.86% |
| 2022 FY | -11.6 Million USD | -39.15% |
| 2022 Q3 | -3.05 Million USD | -14.93% |
| 2021 FY | -8.33 Million USD | -20.25% |
| 2021 Q2 | -1.9 Million USD | -4.08% |
| 2021 Q4 | -2.35 Million USD | -4.72% |
| 2021 Q3 | -2.25 Million USD | -18.43% |
| 2021 Q1 | -1.82 Million USD | -9.74% |
| 2020 FY | -6.93 Million USD | 40.42% |
| 2020 Q1 | -2.22 Million USD | 0.0% |
| 2020 Q4 | -1.66 Million USD | -6.36% |
| 2020 Q3 | -1.56 Million USD | -5.48% |
| 2020 Q2 | -1.48 Million USD | 33.17% |
| 2019 FY | -11.63 Million USD | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Akoya Biosciences, Inc. | -57.66 Million USD | 74.841% |
| AngioDynamics, Inc. | -97.71 Million USD | 85.153% |
| AtriCure, Inc. | -26.68 Million USD | 45.627% |
| Avinger, Inc. | -16.63 Million USD | 12.784% |
| Azenta, Inc. | -73.12 Million USD | 80.16% |
| BioLife Solutions, Inc. | -70.82 Million USD | 79.515% |
| The Cooper Companies, Inc. | 533.1 Million USD | 102.722% |
| Daxor Corporation | -177.07 Thousand USD | -8093.373% |
| Ekso Bionics Holdings, Inc. | -15.11 Million USD | 3.994% |
| GlucoTrack, Inc. | -7.1 Million USD | -104.229% |
| Harvard Bioscience, Inc. | 1.89 Million USD | 866.02% |
| Hologic, Inc. | 882.6 Million USD | 101.644% |
| ICU Medical, Inc. | 22.82 Million USD | 163.564% |
| Intuitive Surgical, Inc. | 1.76 Billion USD | 100.821% |
| KORU Medical Systems, Inc. | -10.26 Million USD | -41.27% |
| LeMaitre Vascular, Inc. | 37.08 Million USD | 139.125% |
| Innovative Eyewear, Inc. | -6.9 Million USD | -110.25% |
| Innovative Eyewear, Inc. | -6.9 Million USD | -110.25% |
| Masimo Corporation | 136.5 Million USD | 110.629% |
| Microbot Medical Inc. | -9.85 Million USD | -47.219% |
| Meihua International Medical Technologies Co., Ltd. | 14.67 Million USD | 198.865% |
| Merit Medical Systems, Inc. | 123.94 Million USD | 111.706% |
| Nephros, Inc. | -1.59 Million USD | -810.761% |
| NovoCure Limited | -232.87 Million USD | 93.77% |
| NEXGEL, Inc. | -3.47 Million USD | -317.268% |
| NEXGEL, Inc. | -3.47 Million USD | -317.268% |
| Singular Genomics Systems, Inc. | -102.8 Million USD | 85.887% |
| OraSure Technologies, Inc. | 54.07 Million USD | 126.828% |
| Pro-Dex, Inc. | 7.17 Million USD | 302.264% |
| Pulse Biosciences, Inc. | -43.57 Million USD | 66.704% |
| Predictive Oncology Inc. | -13.92 Million USD | -4.217% |
| Precision Optics Corporation, Inc. | -2.72 Million USD | -432.549% |
| QuidelOrtho Corporation | 139.1 Million USD | 110.43% |
| Repligen Corporation | 54.57 Million USD | 126.584% |
| Sanara MedTech Inc. | -4.21 Million USD | -244.197% |
| STAAR Surgical Company | 28.09 Million USD | 151.637% |
| Sharps Technology, Inc. | -10.12 Million USD | -43.27% |
| Utah Medical Products, Inc. | 16.77 Million USD | 186.478% |
| DENTSPLY SIRONA Inc. | -85 Million USD | 82.931% |
| Jin Medical International Ltd. | 2.86 Million USD | 606.002% |